Formulation and Evaluation of Orodispersible Tablets of Granisetron Hydrochloride Using Agar as Natural Super disintegrants

C. Sahoo, N. Sahoo, M. Sahu, A. K. Moharana, D. Sarangi
{"title":"Formulation and Evaluation of Orodispersible Tablets of Granisetron Hydrochloride Using Agar as Natural Super disintegrants","authors":"C. Sahoo, N. Sahoo, M. Sahu, A. K. Moharana, D. Sarangi","doi":"10.5530/PHM.2016.7.3","DOIUrl":null,"url":null,"abstract":"The main aim of the study was to develop orodispersible tablets of Granisetron hydrochloride a selective 5-HT3 receptor antagonist (an antivomiting agent) for improving patient compliance, especially those of paediatric and geriatric categories with difficulties in swallowing. In the wet granulation method orodispersible (ORD) tablets were prepared using natural super disintegrants Agar agar. The prepared batches of tablets were evaluated for weight variation, hardness, friability, wetting time, in vitro dispersion time, drug content and in vitro dissolution studies. The tablet formulation batch F4 was considered as the overall best formulation (with an in vitro drug release study of 99.09%). Short term stability studies (at 40 ± 2oC/75 ± 5% RH) on the best formulation indicated that there no significant changes in drug content. From the FTIR study indicated that there are no drug excipient interactions. Key words : Granisetron hydrochloride, Orodispersible tablets, FTIR spectroscopy, Wetting time, In vitro drug release study, Stability studies.","PeriodicalId":19960,"journal":{"name":"Pharmaceutical Methods","volume":"54 1 1","pages":"17-22"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Methods","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/PHM.2016.7.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

The main aim of the study was to develop orodispersible tablets of Granisetron hydrochloride a selective 5-HT3 receptor antagonist (an antivomiting agent) for improving patient compliance, especially those of paediatric and geriatric categories with difficulties in swallowing. In the wet granulation method orodispersible (ORD) tablets were prepared using natural super disintegrants Agar agar. The prepared batches of tablets were evaluated for weight variation, hardness, friability, wetting time, in vitro dispersion time, drug content and in vitro dissolution studies. The tablet formulation batch F4 was considered as the overall best formulation (with an in vitro drug release study of 99.09%). Short term stability studies (at 40 ± 2oC/75 ± 5% RH) on the best formulation indicated that there no significant changes in drug content. From the FTIR study indicated that there are no drug excipient interactions. Key words : Granisetron hydrochloride, Orodispersible tablets, FTIR spectroscopy, Wetting time, In vitro drug release study, Stability studies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
琼脂为天然超级崩解剂的盐酸格拉司琼多孔分散片的研制与评价
该研究的主要目的是开发盐酸格拉司琼的口服分散片,这是一种选择性5-HT3受体拮抗剂(一种止吐剂),用于改善患者的依从性,特别是那些患有吞咽困难的儿童和老年人。采用湿造粒法,采用天然超级崩解剂琼脂制备orodispersible片剂。对所制片剂进行重量变化、硬度、脆性、润湿时间、体外分散时间、药物含量和体外溶出度等评价。认为片剂F4批次为整体最佳制剂(体外释药率为99.09%)。短期稳定性研究(40±20℃/75±5% RH)表明,最佳配方的药物含量无明显变化。从红外光谱研究表明,没有药物赋形剂相互作用。关键词:盐酸格拉司琼,孔分散片,FTIR光谱,润湿时间,体外释药研究,稳定性研究
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A New HPTLC Method for Analysis of Artemisinin Derivatives (Artemether and Lumefantrine) in Bulk Drug and Liposomal Formulation: Stress Degradation Study Analytical Validation and Stability Indicating Studies for Simultaneous Estimation of Benidepine and Metoprolol by Strong Cation Exchange (SCX) Chromatography Validated RP-HPLC Method Development of Pazopanib in Bulk and its Pharmaceutical Dosage Form A Novel Rapid Approach for the Estimation of Ketoconazole Using Reverse Phase Ultra Performance Liquid Chromatography in Bulk and Tablet Dosage from RP-HPLC and Spectrophotometric determination of rutin Trihydrate, Berberine chloride and trigonelline Hydrochloride in Antidiabetic Polyherbal Formulations
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1